These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30256630)

  • 21. Selective Coupling of Click Anchors to Proteins via Trypsiligase.
    Meyer C; Liebscher S; Bordusa F
    Bioconjug Chem; 2016 Jan; 27(1):47-53. PubMed ID: 26670641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
    Kashihara M; Azuma K; Kawahara A; Basaki Y; Hattori S; Yanagawa T; Terazaki Y; Takamori S; Shirouzu K; Aizawa H; Nakano K; Kage M; Kuwano M; Ono M
    J Thorac Oncol; 2009 Sep; 4(9):1066-74. PubMed ID: 19648825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In situ study of RSK2 kinase activity in a single living cell by combining single molecule spectroscopy with activity-based probes.
    Yu S; Du Z; Dong C; Ren J
    Analyst; 2019 Jun; 144(12):3756-3764. PubMed ID: 31070195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycerol-based contrast agents: a novel series of dendronized pentamethine dyes.
    Wycisk V; Pauli J; Welker P; Justies A; Resch-Genger U; Haag R; Licha K
    Bioconjug Chem; 2015 Apr; 26(4):773-81. PubMed ID: 25811535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
    J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2.
    Maadi H; Nami B; Tong J; Li G; Wang Z
    BMC Cancer; 2018 Mar; 18(1):238. PubMed ID: 29490608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proximity-Induced Site-Specific Antibody Conjugation.
    Yu C; Tang J; Loredo A; Chen Y; Jung SY; Jain A; Gordon A; Xiao H
    Bioconjug Chem; 2018 Nov; 29(11):3522-3526. PubMed ID: 30372039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On-bead antibody-small molecule conjugation using high-capacity magnetic beads.
    Nath N; Godat B; Benink H; Urh M
    J Immunol Methods; 2015 Nov; 426():95-103. PubMed ID: 26316179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.
    Olafsen T; Kenanova VE; Sundaresan G; Anderson AL; Crow D; Yazaki PJ; Li L; Press MF; Gambhir SS; Williams LE; Wong JY; Raubitschek AA; Shively JE; Wu AM
    Cancer Res; 2005 Jul; 65(13):5907-16. PubMed ID: 15994969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
    Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
    Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of DOTA-conjugated antibody fragments for radioimmunoimaging.
    Smith-Jones PM; Solit DB
    Methods Enzymol; 2004; 386():262-75. PubMed ID: 15120256
    [No Abstract]   [Full Text] [Related]  

  • 32. Localized Visualization and Autonomous Detection of Cell Surface Receptor Clusters Using DNA Proximity Circuit.
    Ang YS; Li JJ; Chua PJ; Ng CT; Bay BH; Yung LL
    Anal Chem; 2018 May; 90(10):6193-6198. PubMed ID: 29608843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells.
    Yang L; Li Y; Shen E; Cao F; Li L; Li X; Wang X; Kariminia S; Chang B; Li H; Li Q
    Int J Oncol; 2017 Nov; 51(5):1553-1562. PubMed ID: 29048656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy.
    Yonemori K; Tsuta K; Shimizu C; Hatanaka Y; Hirakawa A; Ono M; Kouno T; Katsumata N; Ando M; Tamura K; Hasegawa T; Kinoshita T; Fujiwara Y
    J Surg Oncol; 2010 Mar; 101(3):222-7. PubMed ID: 20087905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.
    Steffensen KD; Waldstrøm M; Andersen RF; Olsen DA; Jeppesen U; Knudsen HJ; Brandslund I; Jakobsen A
    Int J Oncol; 2008 Jul; 33(1):195-204. PubMed ID: 18575766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ErbB receptors and their ligands in cancer: an overview.
    Normanno N; Bianco C; Strizzi L; Mancino M; Maiello MR; De Luca A; Caponigro F; Salomon DS
    Curr Drug Targets; 2005 May; 6(3):243-57. PubMed ID: 15857286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer.
    Kanthala S; Banappagari S; Gokhale A; Liu YY; Xin G; Zhao Y; Jois S
    Chem Biol Drug Des; 2015 Jun; 85(6):702-714. PubMed ID: 25346057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Her2/neu membrane protein clusters in different types of breast cancer cells using localization microscopy.
    Kaufmann R; Müller P; Hildenbrand G; Hausmann M; Cremer C
    J Microsc; 2011 Apr; 242(1):46-54. PubMed ID: 21118230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent.
    Dennis MS; Jin H; Dugger D; Yang R; McFarland L; Ogasawara A; Williams S; Cole MJ; Ross S; Schwall R
    Cancer Res; 2007 Jan; 67(1):254-61. PubMed ID: 17210705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.